Statera Biopharma, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Statera Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2022.
  • Statera Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$1.81M, a 41.4% increase year-over-year.
  • Statera Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$3.66M, a 34.7% increase year-over-year.
  • Statera Biopharma, Inc. annual Nonoperating Income (Expense) for 2021 was -$3.53M, a 122% decline from 2020.
  • Statera Biopharma, Inc. annual Nonoperating Income (Expense) for 2020 was -$1.59M, a 377% decline from 2019.
  • Statera Biopharma, Inc. annual Nonoperating Income (Expense) for 2019 was -$334K, a 131% decline from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$3.66M -$1.81M +$1.28M +41.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$4.94M -$637K -$355K -126% Apr 1, 2022 Jun 30, 2022 10-Q 2022-10-28
Q1 2022 -$4.59M -$1.15M -$1.05M -1138% Jan 1, 2022 Mar 31, 2022 10-Q 2022-10-21
Q4 2021 -$3.53M -$67.8K +$2.07M +96.8% Oct 1, 2021 Dec 31, 2021 10-K 2022-10-06
Q3 2021 -$5.61M -$3.09M -$3.58M -728% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$2.02M -$282K -$497K -231% Apr 1, 2021 Jun 30, 2021 10-Q 2022-10-28
Q1 2021 -$1.53M -$92.6K +$64.8K +41.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-10-21
Q4 2020 -$1.59M -$2.14M -$1.72M -410% Oct 1, 2020 Dec 31, 2020 10-K 2022-10-06
Q3 2020 $130K $492K +$441K +864% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$310K $216K +$77.6K +56.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$388K -$157K -$54.3K -52.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$334K -$420K -$600K -333% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 $266K $51K -$88.4K -63.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $354K $138K -$57.5K -29.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $412K -$103K -$681K -118% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $1.09M $180K +$165K +1068% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-15
Q3 2018 $928K $139K +$238K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $690K $195K +$4.27M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$3.58M $578K +$658K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$4.24M $15.4K -$646K -97.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$3.6M -$99K -$1.95M -105% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$1.64M -$4.08M -$3.69M -940% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $2.04M -$80.6K -$1.72M -105% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $3.77M $662K +$519K +363% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 $3.25M $1.85M +$2.25M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $994K -$392K +$1.22M +75.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$225K $1.64M +$2.03M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$2.25M $143K -$14M -99% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-22
Q3 2015 $11.7M -$399K +$778K +66.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $11M -$1.61M -$1.49M -1253% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $12.5M -$387K -$2M -124% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $14.5M $14.1M +$12M +557% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-23
Q3 2014 $2.47M -$1.18M -$2.42M -194% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $4.9M -$119K -$3.01M -104% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $7.9M $1.62M +$4.96M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $2.95M $2.15M -$5.62M -72.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 $8.56M $1.25M +$5.72M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $2.84M $2.89M -$365K -11.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $3.21M -$3.34M -$4.42M -408% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $7.63M $7.77M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 -$4.47M -$8.56M -210% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $3.25M -$14.5M -81.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $1.08M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 $4.08M +$10.4M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $17.8M +$17.8M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q3 2010 -$6.32M Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-11-14
Q2 2010 -$91.6K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.